Cargando…
Targeted therapies in non-small cell lung cancer
Chemotherapy now has an established role in the treatment of non-small cell lung cancer, with randomised evidence supporting a survival benefit in both advanced disease and the adjuvant setting. The availability of newer cytotoxic agents has not led to further improvement in outcome, and novel appro...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
e-Med
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2590876/ https://www.ncbi.nlm.nih.gov/pubmed/19028612 http://dx.doi.org/10.1102/1470-7330.2008.0027 |